Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

ALAMEDA, Calif., Feb. 22, 2024 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2023. Financial Highlights: Revenue of $284.7 million for the…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks